COVID-19: Advice for people living with Pulmonary Fibrosis
This fact sheet provides general information and advice for people living with Pulmonary Fibrosis on how to stay safe during the COVID-19 pandemic.
View more3 March 2021 – Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) Consensus Statement on COVID-19 Vaccination for Adults Living with Interstitial Lung Disease (ILD)
The CRE-PF COVID-19 Working Group is strongly supportive of the Australian Government rollout of Therapeutic Goods Administration (TGA) approved COVID-19 vaccines.
This includes support of COVID-19 vaccination for adults living with interstitial lung disease who may be immunocompromised. All COVID-19 vaccinations approved for use in Australia are effective in reducing rates of COVID-19-related infection, hospitalisation and risk of severe disease.
People living with interstitial lung disease should speak to their treating healthcare team if they have concerns about their specific health circumstances.